Gregory Adams

Gregory Adams

Company: Elucida Oncology

Job title: Chief Scientific Officer

Seminars:

Folate Receptor Alpha Targeted Topiosomerase 1 CDC For Platinum Resistant Ovarian Cancer 5:00 pm

Overviewing novel targeted CDot Conjugates for the treatment of Folate Receptor Alpha over-expressing tumors Reviewing how CDC multivalent tumor targeting and high payload loading allows for the more effective killing of tumors with lower target antigen expression Exploring how Elucida’s CDC can be expanded into other FR+/Topo1 responsive indicationsRead more

day: day 2- pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.